Laurie Connors speaks to ecancer about genomic testing in prostate cancer.

She covers the genomic testing options before diagnosis such as Polygenic Risk Score, and then discusses the range of profiling assays during diagnosis.

Laurie then covers some genomic analysis tools for understanding disease progression such as ctDNA.

She finishes by highlighting some of the future prospects for genomic testing in prostate cancer at the bedside.